4 Science Park
3rd Floor
New Haven, CT 06511
United States
203 787 7888
https://www.precipiodx.com
Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 51
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Ilan Danieli | Founder, President, CEO & Director | 325,06k | N/A | 1972 |
Mr. Ahmed Zaki Sabet | Chief Operating Officer | 220,82k | N/A | 1986 |
Dr. Ayman A. Mohamed M.D. | Chief Technology Officer | 225,15k | N/A | 1985 |
Mr. Matthew Gage | Chief Financial Officer | N/A | N/A | 1967 |
Ms. Miri Chiko-Radomski | Chief Legal Counsel & People Officer | N/A | N/A | N/A |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Precipio, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.